Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

HKG/1093 stock hub

HKG/1093 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HKG/1093is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
93.8B
Hong Kong Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
HKG/1093
In the news

Latest news · HKG/1093

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.8
P25 11.7P50 18.9P75 41.4
Trailing P/E21.7
P25 10.7P50 17.9P75 38.5
ROE11.3
P25 -14.7P50 2P75 9.4
ROIC12.7
P25 -10.4P50 1.9P75 10.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HKG/1093 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
246
Groups with data
11
Currency
CNY
Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Hong Kong
Country code
HK
Employees
19,700
Employees Change
-1,700%
Employees Change Percent
-7.94
Enterprise value
HKD 84.4B
Exchange
Hong Kong Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Drug Manufacturers - General
Isin
HK1093012172
Last refreshed
2026-05-10
Market cap
HKD 93.8B
Price
HKD 8.2
Price currency
HKD
Rev Per Employee
1,469,021.37x
Sector
Healthcare
Sic
2834
Symbol
hkg/1093
Website
https://www.cspc.com.hk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

15
MetricValue
Earnings Yield
4.61%
EV Earnings
19.55x
EV/EBIT
19.42x
EV/EBITDA
14.51x
EV/FCF
19.6x
EV/Sales
2.92x
FCF yield
4.6%
Forward P/E
12.8x
P/B ratio
2.44x
P/E ratio
21.69x
P/S ratio
3.24x
PE Ratio10 Y
20.92x
PE Ratio3 Y
14.66x
PE Ratio5 Y
15.06x
PEG ratio
0.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
15.23%
EBITDA Margin
19.65%
FCF margin
14.89%
Gross margin
65.59%
Gross Profit
HKD 19B
Gross Profit Growth
-15.96%
Gross Profit Growth Q
-7.05%
Gross Profit Growth3 Y
-8.48%
Gross Profit Growth5 Y
-1.81%
Net Income
HKD 4.3B
Net Income Growth
-10.3%
Net Income Growth Q
-32.6%
Net Income Growth Years
0%
Net Income Growth3 Y
-13.94%
Net Income Growth5 Y
-5.53%
Pretax Margin
18.49%
Profit Margin
14.93%
Profit Per Employee
HKD 219,292
Profitable Years
23
ROA
5.44
Roa5y
9.18
ROCE
10.85
ROE
11.33
Roe5y
17.25
ROIC
12.65
Roic5y
25.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

26
MetricValue
Cagr10y
11.6%
Cagr15y
10.93%
Cagr1y
47.22%
Cagr20y
15.56%
Cagr3y
4.5%
Cagr5y
0.21%
Div CAGR10
16.51%
Div CAGR3
6.27%
Div CAGR5
8.11%
EPS Growth
-7.84
EPS Growth Q
-31.67
EPS Growth Years
0
EPS Growth3 Y
-12.72
EPS Growth5 Y
-4.67
FCF Growth
53.7%
FCF Growth3 Y
-10.53%
FCF Growth5 Y
-6.38%
OCF Growth
28.6%
OCF Growth10 Y
11.96%
OCF Growth3 Y
-8.56%
OCF Growth5 Y
-2.85%
Revenue Growth
-10.35x
Revenue Growth Q
-3.29x
Revenue Growth Years
0x
Revenue Growth3 Y
-5.62x
Revenue Growth5 Y
0.84x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
HKD 0.57
Assets
HKD 52B
Cash
HKD 11.5B
Current Assets
HKD 25.6B
Current Liabilities
HKD 11.7B
Debt
HKD 713.4M
Debt EBITDA
HKD 0.12
Debt Equity
HKD 0.02
Debt FCF
HKD 0.17
Equity
HKD 38.4B
Interest Coverage
102.6
Liabilities
HKD 13.5B
Long Term Assets
HKD 26.3B
Long Term Liabilities
HKD 1.8B
Net Cash
HKD 10.8B
Net Cash By Market Cap
HKD 11.55
Net Cash Growth
12.77%
Net Debt EBITDA
HKD -1.9
Net Debt Equity
HKD -0.28
Net Debt FCF
HKD -2.51
Tangible Book Value
HKD 33.7B
Tangible Book Value Per Share
HKD 2.95
WACC
8.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.19
Inventory Turnover
2.88
Net Working Capital
HKD 2.4B
Quick ratio
1.88
Working Capital
HKD 13.4B
Working Capital Turnover
HKD 2.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
2.68%
Dividend Growth
-20%
Dividend Growth Years
0%
Dividend per share
HKD 0.29
Dividend Years
13
Dividend Yield
3.54%
Ex Div Date
2026-06-24
Last Dividend
HKD 0.14
Payout Frequency
Semi-Annual
Payout Ratio
64.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
199.64%
1Y total return
47.18%
200-day SMA
9.14
3Y total return
14.11%
50-day SMA
8.99
50-day SMA vs 200-day SMA
50under200
5Y total return
1.06%
All Time High
13.93
All Time High Change
-41.14%
All Time High Date
2018-05-28
All Time Low
0.1
All Time Low Change
7,716.97%
All Time Low Date
1998-01-12
ATR
0.34
Beta
0.8
Beta1y
0.75
Beta2y
0.35
Ch YTD
-2.73
High
8.23
High52
11.63
High52 Date
2025-09-09
High52ch
-29.49%
Low
8.08
Low52
5.34
Low52 Date
2025-05-12
Low52ch
53.56%
Ma50ch
-8.82%
Price vs 200-day SMA
-10.32%
RSI
36.93
RSI Monthly
52.26
RSI Weekly
43.14
Sharpe ratio
0.8x
Sortino ratio
1.4
Total Return
6.21%
Tr YTD
-2.73
Tr15y
373.82%
Tr1m
-15.55%
Tr1w
-3.3%
Tr3m
-15.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
HKD 4.4B
Operating Income Growth
-26.18
Operating Income Growth Q
-32.8
Operating Income Growth3 Y
-16.32
Operating Income Growth5 Y
-6.26
Operating margin
15.23

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
7,723,373,946%
Net Borrowing
-167,990,017.9
Shares Insiders
25.84%
Shares Institutions
36.27%
Shares Out
11,433,024,932
Shares Qo Q
-0.19%
Shares Yo Y
-2.68%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

68
MetricValue
Adjusted FCF
HKD 4.4B
Average Volume
72,781,692.65x
Bv Per Share
3.23
CAPEX
HKD -2.2B
Ch10y
140.4
Ch15y
242.2
Ch1m
-15.55
Ch1w
-3.3
Ch1y
43.11
Ch20y
1,075
Ch3m
-15.11
Ch3y
1.61
Ch5y
-13.68
Ch6m
11.11
Change
-0.73%
Change From Open
0.86
Close
8.26
Days Gap
-1.57
Depreciation Amortization
1,323,613,480.7
Dollar Volume
552,265,965.6
Earnings Date
2026-05-27
EBIT
HKD 4.4B
EBITDA
HKD 5.7B
EPS
HKD 0.38
F Score
4
FCF
HKD 4.3B
FCF EV Yield
5.1x
FCF Per Share
HKD 0.38
Financing CF
-2,906,293,140
Fiscal Year End
December
Founded
1,992
Goodwill
270,506,767
Graham Number
5.347
Graham Upside
-34.79
Income Tax
HKD 1B
Investing CF
-4,315,517,090
Is Primary Listing
1
Last Earnings Date
2026-03-25
Last Report Date
2025-12-31
Last Split Date
2020-10-15
Last Split Type
Forward
Lynch Fair Value
HKD 1.89
Lynch Upside
-76.96
Ma150
8.83
Ma150ch
-7.16%
Ma20
8.77
Ma20ch
-6.49%
Net CF
-737,657,432
Next Earnings Date
2026-05-27
Open
8.13
P FCF Ratio
21.76
P OCF Ratio
14.45
Payment Date
2025-11-18
Position In Range
80
Ppne
15,533,911,899.1
Price Date
2026-05-08
Price EBITDA
HKD 16.49
Ptbv Ratio
2.78
Relative Volume
0.93x
Revenue
28,939,721,053x
SBC By Revenue
-0.25x
Share Based Comp
-73,387,610
Tax By Revenue
3.58x
Tax Rate
19.38%
Tr20y
1,703.19%
Tr6m
11.11%
Volume
67,349,508
Z Score
5.78
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

HKG/1093 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.5%
$0.29 annual per share
Payout ratio
+64.3%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+8.1%
0 consecutive years of growth
Total shareholder yield
+6.2%
Next ex-dividend date: 2026-06-24
Performance

HKG/1093 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+47.2%
S&P 500 1Y: n/a
3Y total return
+14.1%
S&P 500 3Y: n/a
5Y total return
+1.1%
S&P 500 5Y: n/a
10Y total return
+199.6%
S&P 500 10Y: n/a
Ownership

Who owns HKG/1093?

Insider, institutional, and short-interest positioning.

Institutional ownership
+36.3%
Share of float held by funds and institutions
Insider ownership
+25.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-2.7%
Negative means the company is buying back shares.
Technical

HKG/1093 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
36.9
Neutral momentum band
Price vs 200-day MA
-10.3%
50/200-day relationship not available
Beta (5Y)
0.80
Less volatile than the market
Sharpe ratio
0.80
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HKG/1093

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1093 stock rating?

hkg/1093 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1093 analysis?

The full report lives at /stocks/hkg/1093/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1093?

The latest report frames hkg/1093 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1093 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.